[ad_1] Liselotte Sabroe | Afp | Getty Images Novo Nordisk on Thursday said it will acquire Inversago Pharma, a privately held obesity drug maker, for up to $1.08 billion to broaden the Danish company’s blockbuster weight loss portfolio. The deal is Novo Nordisk’s latest attempt to capitalize on the weight loss industry gold rush, which…
[ad_1] A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. Jim Vondruska | Reuters Novo Nordisk‘s obesity drug Wegovy slashed the risk of serious heart problems by 20% in a large clinical trial – a landmark finding that could put…
[ad_1] Sopa Images | Lightrocket | Getty Images Eli Lilly on Tuesday raised its full-year guidance as second-quarter profit jumped 85% from the same period a year ago on strong sales from the pharmaceutical giant’s drug pipeline. The company now expects full-year revenue of between $33.4 billion and $33.9 billion, up from a previous forecast…
[ad_1] The findings of the study were reported in the journal Nutrients. “Obesity and diabetes numbers are increasing in modern society worldwide, and the trend in high-fat diet consumption is one of the main reasons besides lifestyle and genetic predisposition,” said Luis Cisneros-Zevallos, Ph.D., professor of horticulture and food science in the Department of Horticultural…
[ad_1] Poor lifestyle habits, obesity, sleep deprivation and consumption of junk and processed food are the important reasons for blood pressure (BP) in youth and adolescents, according to leading physician Dr V. Jagadeesh Kumar. The consultant physician at KIMS Hospitals, Secunderabad, says that there is no disease called low BP. A person’s BP might…
[ad_1] The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, September 17, 2020. Mike Blake | Reuters An Eli Lilly experimental drug helped patients lose about 26% of their weight on average following extended use or intensive lifestyle changes, according to results from two studies released Thursday. It’s…
[ad_1] Packages of the weight-loss drug Wegovy from the pharmaceutical company Novo Nordisk lie on the sales counter in a Danish pharmacy. Stefan Trumpf | Picture Alliance | Getty Images U.K. health authorities on Wednesday said they are reviewing obesity and diabetes drugs like Novo Nordisk‘s Wegovy and Ozempic after some patients who took the…
[ad_1] When you have a child, each tiny milestone of theirs brings you happiness and joy. Be it the first time they grab your finger or the first few steps they take, each development makes your heart leap with joy. But, with each new step, parents are also constantly worried about their health and well-being….
[ad_1] As per a new study, children who suffer racial discrimination are more likely to have a higher BMI and a wider waistline later in life. The findings, published in JAMA Network Open, suggest that, in addition to other socioeconomic factors such as family poverty, racial discrimination may be a risk factor for young people…
[ad_1] Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly on Friday said it will acquire Versanis, a privately held obesity drug maker, for up to $1.93 billion to boost the pharmaceutical giant’s weight loss treatment portfolio. Eli Lilly agreed to pay Versanis shareholders…
